What's new

Human medicines European public assessment report (EPAR): Sugammadex Amomed, sugammadex, Date of authorisation: 10/01/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Sugammadex Amomed, sugammadex, Date of authorisation: 10/01/2023, Revision: 3, Status: Authorised

Mar 25, 2025 - 14:08
 0
Human medicines European public assessment report (EPAR): Sugammadex Amomed, sugammadex, Date of authorisation: 10/01/2023, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Sugammadex Amomed, sugammadex, Date of authorisation: 10/01/2023, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Inside the VW ID. Matrix Headlights – A Deep Dive!

Next Article

Trump puts Venezuelan oil importers in tariff crosshairs

Related Posts

Drug-Eluting stent (DES) - Notified Body 2265 - 10/01/2...

Mar 13, 2025  0

Quality Working Party

Quality Working Party

Feb 9, 2025  0

Q&A clinic on web-based electronic Application Form (eAF) functionalities for CAPs and non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 March 2025, 11:30 (CET) to 13 March 2025, 12:00 (CET)

Q&A clinic on web-based electronic Application Form (eA...

Mar 10, 2025  0